Transdermal and oral hormone replacement therapy and the risk of stroke
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458520/0/grapherence/d458520.
Transdermal and oral hormone replacement therapy and the risk of stroke. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458520/0/grapherence/d458520. Accessed April 28, 2024.
Transdermal and oral hormone replacement therapy and the risk of stroke. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458520/0/grapherence/d458520
Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458520/0/grapherence/d458520.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transdermal and oral hormone replacement therapy and the risk of stroke
ID - 458520
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458520/0/grapherence/d458520
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -